Obesity and coronary risk in patients treated with second-generation antipsychotics

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

(2010) Elaine H. Morrato et al.   ARCHIVES OF GENERAL PSYCHIATRY

Impact of Tobacco Smoking on Lipid Metabolism, Body Weight and Cardiometabolic Risk

(2010) Amalia Gastaldelli et al.   CURRENT PHARMACEUTICAL DESIGN

Predictors of insulin resistance in the obese with metabolic syndrome

(2010) Peter Manu et al.   European Journal of Internal Medicine

Metabolic Syndrome and Risk of Acute Myocardial Infarction

(2010) Andrew Mente et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Central Obesity and Multivariable Cardiovascular Risk as Assessed by the Framingham Prediction Scores

(2009) Satvinder S. Dhaliwal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men

(2009) Johan Ärnlöv et al.   CIRCULATION

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle-aged Japanese

(2009) Rie Oka et al.   Obesity

The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering

(2008) Rachel P. Wildman   ARCHIVES OF INTERNAL MEDICINE

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study

(2008) Celso Arango et al.   SCHIZOPHRENIA RESEARCH